Deutsch English Français

Contact

EP1063982

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1063982

EP1063982 - ANTAGONISTS FOR TREATMENT OF CD11/CD18 ADHESION RECEPTOR MEDIATED DISORDERS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 21.12.2007 Database last updated on 29.06.2024
Most recent event Tooltip	08.01.2010	Lapse of the patent in a contracting state New state(s): CY, LU	published on 10.02.2010 [2010/06]
Applicant(s)	For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US
	[N/P]
Former [2007/07]	For all designated states GENENTECH, INC. 1 DNA Way South San Francisco, CA 94080-4990 / US
Former [2001/01]	For all designated states Genentech, Inc. 1 DNA Way South San Francisco, CA 94080-4990 / US
Inventor(s)	01 / Burdick, Daniel, J. 1404 Palm Drive Burlingame, CA 94010 / US
	02 / McDowell, Robert S. 1264 Church Street San Francisco, CA 94114 / US
	03 / Oare, David 1622 Ralston Avenue Belmont, CA 94002 / US
	04 / Stanley, Mark S. 284 Lauren Avenue Pacifica, CA 94041 / US
	05 / Gadek, Thomas R. 2838 Chelsea Drive Oakland, CA 94611 / US
	06 / Marsters, James C. 809 McKinley Oakland, CA 94611 / US
	07 / Reynolds, Mark 175 Linda Vista Millbrae, CA 94030 / US
	08 / Weese, Kenneth J. 740 Palm Avenue South San Francisco, CA 94080 / US
	[2001/01]
Representative(s)	Barz, Peter Meissner Bolte & Partner GbR Postfach 86 06 24 81633 München / DE
	[N/P]
Former [2009/30]	Barz, Peter Patentanwalt Kaiserplatz 2 80803 München / DE
Former [2001/01]	Barz, Peter Kaiserplatz 2 80803 München / DE
Application number, filing date	99912869.7	24.03.1999
	[2001/01]
	WO1999US06410
Priority number, date	US19980079732P	27.03.1998 Original published format: US 79732 P
	[2001/01]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO9949856
	Date:	07.10.1999
	Language:	EN
	[1999/40]
	Type:	A2 Application without search report
	No.:	EP1063982
	Date:	03.01.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 07.10.1999 takes the place of the publication of the European patent application.
	[2001/01]
	Type:	B1 Patent specification
	No.:	EP1063982
	Date:	14.02.2007
	Language:	EN
	[2007/07]
Search report(s)	International search report - published on:	EP	18.11.1999
Classification	IPC:	A61K31/195, A61K31/275, A61K31/40, A61K31/425, A61K31/445, A61K31/405, A61K31/38, A61K31/27, A61K31/34, A61P37/00	[2005/49]
	CPC:	A61K31/4458 (EP,US); A61K31/559 (KR); A61K31/166 (EP,US); A61K31/18 (EP,US); A61K31/341 (EP,US); A61K31/343 (EP,US); (+) A61K31/36 (EP,US); A61K31/381 (EP,US); A61K31/40 (EP,US); A61K31/404 (EP,US); A61K31/415 (EP,US); A61K31/4164 (EP,US); A61K31/4192 (EP,US); A61K31/433 (EP,US); A61K31/445 (EP,US); A61P11/06 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P25/00 (EP); A61P29/00 (EP); A61P37/00 (EP); A61P37/02 (EP); A61P37/04 (EP); A61P37/06 (EP); A61P37/08 (EP); A61P43/00 (EP) (-)
	Former IPC [2001/01]	A61K31/195, A61K31/275, A61K31/40, A61K31/425, A61K31/445, A61K31/405, A61K31/38, A61K31/27, A61K31/34
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/01]
Extension states	AL	08.09.2000
	LT	08.09.2000
	LV	08.09.2000
	MK	08.09.2000
	RO	08.09.2000
	SI	08.09.2000
Title	German:	ANTAGONISTE ZUR BEHANDLUNG VON CD11/CD18 ADHÄSIONSREZEPTOR-VERMITTELTEN KRANKHEITEN	[2001/01]
	English:	ANTAGONISTS FOR TREATMENT OF CD11/CD18 ADHESION RECEPTOR MEDIATED DISORDERS	[2001/01]
	French:	ANTAGONISTES DESTINES AU TRAITEMENT DE TROUBLES INDUITS PAR LE RECEPTEUR D'ADHESION DE CD11/CD18	[2001/01]
Entry into regional phase	01.08.2000	National basic fee paid
	01.08.2000	Designation fee(s) paid
	01.08.2000	Examination fee paid
Examination procedure	15.10.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	01.08.2000	Examination requested [2001/01]
	18.09.2002	Despatch of a communication from the examining division (Time limit: M06)
	28.03.2003	Reply to a communication from the examining division
	17.07.2003	Despatch of a communication from the examining division (Time limit: M06)
	27.01.2004	Reply to a communication from the examining division
	10.02.2004	Despatch of a communication from the examining division (Time limit: M06)
	13.08.2004	Reply to a communication from the examining division
	28.11.2005	Communication of intention to grant the patent
	06.04.2006	Fee for grant paid
	06.04.2006	Fee for publishing/printing paid
Divisional application(s)	EP06015229.5 / EP1754705
Opposition(s)	15.11.2007	No opposition filed within time limit [2008/04]
Fees paid	Renewal fee
	16.03.2001	Renewal fee patent year 03
	13.03.2002	Renewal fee patent year 04
	11.03.2003	Renewal fee patent year 05
	15.03.2004	Renewal fee patent year 06
	14.03.2005	Renewal fee patent year 07
	09.03.2006	Renewal fee patent year 08
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	14.02.2007
	DK	14.02.2007
	FI	14.02.2007
	NL	14.02.2007
	LU	24.03.2007
	IE	26.03.2007
	MC	31.03.2007
	GR	15.05.2007
	ES	25.05.2007
	PT	16.07.2007
	[2010/06]
Former [2008/21]	DK	14.02.2007
	FI	14.02.2007
	NL	14.02.2007
	IE	26.03.2007
	MC	31.03.2007
	GR	15.05.2007
	ES	25.05.2007
	PT	16.07.2007
Former [2008/17]	DK	14.02.2007
	FI	14.02.2007
	NL	14.02.2007
	IE	26.03.2007
	MC	31.03.2007
	ES	25.05.2007
	PT	16.07.2007
Cited in	International search	[X]JPH05306226 ;
		[X]EP0325343 (UNIV PRINCETON [US], et al) [X] 1,9-15 * abstract * * page 4, line 54 - page 5, line 38; example -; claim - *;
		[X]EP0452660 (UNIV PRINCETON [US]) [X] 1,9-15 * abstract * * page 5, line 20 - line 23; example -; claim - *;
		[X]EP0530537 (TAKEDA CHEMICAL INDUSTRIES LTD [JP]) [X] 1,9-15 * abstract * * page 27, line 47 - line 48 ** page 28, line 17 - line 20; example -; claim - *;
		[X]WO9413295 (AGOURON PHARMA [US], et al) [X] 1,9-15 * abstract * * page 5, line 16 - line 24; example -; claim - *;
		[X]WO9708133 (JAPAN TOBACCO INC [JP], et al) [X] 1,9-15;
		EP0849256 [ ] (JAPAN TOBACCO INC [JP]) [ ] * abstract * * page 25, line 17 - line 27; examples 2,58-70,100-103,129,134,135; claim -; table - *;
		[PX]WO9910312 (HOFFMANN LA ROCHE [CH]) [PX] 1-6,9-15 * abstract * * page 14, line 1 - page 22, line 35; claim - *;
		[E]WO9926923 (MERCK & CO INC [US], et al) [E] 1-6,9-15 * the whole document *;
		[E]WO9936393 (TANABE SEIYAKU CO [JP], et al) [E] 1-3,9-15 * abstract * * page 27, paragraph 1 - page 31, paragraph 2 * * example 202; table 14 * * claim - *;
		[X] - DATABASE WPI, 1, Derwent World Patents Index, vol. 93, no. 51, Database accession no. 93-408840, XP002115880 & JPH05306226 A 19931119 (TAKEDA CHEM IND LTD) [X] 1,9-15 * abstract *
		[ ] - CHEMICAL ABSTRACTS, (19940404), vol. 120, no. 14, Database accession no. 173481 [ ] * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p